Tan Mingjuan, Law Lawrence Siu-Chun, Gan Tong Joo
Duke-NUS Graduate Medical School, Singapore, Singapore.
Can J Anaesth. 2015 Feb;62(2):203-18. doi: 10.1007/s12630-014-0275-x. Epub 2014 Dec 10.
The optimal management of postoperative pain using multimodal analgesia is a key component of Enhanced Recovery After Surgery (ERAS). Pain has adverse clinical implications on postoperative recovery, including prolonging the time to recovery milestones and length of hospital stay. Moreover, the ubiquity of opioids in postoperative analgesic regimens results in adverse effects, such as sedation, postoperative nausea and vomiting, urinary retention, ileus, and respiratory depression, which can delay discharge. Thus, multimodal analgesia, i.e., the use of more than one analgesic modality to achieve effective pain control while reducing opioid-related side effects, has become the cornerstone of enhanced recovery. The purpose of this review is to address the analgesic techniques used as part of multimodal analgesic regimens to optimize postoperative pain control and to summarize the evidence for their use in reducing opioid requirements and side effects.
There is a wide variety of analgesic techniques available for multimodal postoperative analgesia. These modalities are divided into pharmacological and non-pharmacological techniques. Systemic pharmacological modalities involve opioids and non-opioids such as acetaminophen, non-steroidal anti-inflammatory drugs, N-methyl-D-aspartate receptor antagonists, anticonvulsants (e.g., gamma-aminobutyric acid analogues), beta-blockers, alpha-2 agonists, transient receptor potential vanilloid receptor agonists (capsaicin), and glucocorticoids. Other pharmacological modalities include central neuraxial techniques, surgical-site infiltration, and regional anesthesia. Evidence supports the use of these pharmacological techniques as part of multimodal analgesia, but each has its own advantages and specific safety profile, which highlights the importance of selecting the appropriate analgesics for each patient. Adjunctive non-pharmacological techniques include acupuncture, music therapy, transcutaneous electrical nerve stimulation, and hypnosis. There is mixed evidence regarding such techniques, although a lack of harm is associated with their use.
There are continuing advancements in multimodal analgesic techniques; however, postoperative pain in general continues to be undermanaged. Furthermore, a continuing challenge in multimodal pain research related to ERAS is the difficulty in carrying out randomized trials to determine the relative importance of any one component, including analgesia.
使用多模式镇痛对术后疼痛进行优化管理是术后加速康复(ERAS)的关键组成部分。疼痛对术后恢复具有不良临床影响,包括延长恢复到各里程碑的时间以及住院时间。此外,阿片类药物在术后镇痛方案中普遍使用会导致不良反应,如镇静、术后恶心和呕吐、尿潴留、肠梗阻以及呼吸抑制,这些都可能延迟出院。因此,多模式镇痛,即使用一种以上的镇痛方式来实现有效的疼痛控制,同时减少与阿片类药物相关的副作用,已成为加速康复的基石。本综述的目的是探讨作为多模式镇痛方案一部分所使用的镇痛技术,以优化术后疼痛控制,并总结其在减少阿片类药物需求和副作用方面的应用证据。
多模式术后镇痛有多种镇痛技术可供选择。这些方式分为药理学和非药理学技术。全身性药理学方式包括阿片类药物和非阿片类药物,如对乙酰氨基酚、非甾体抗炎药、N-甲基-D-天冬氨酸受体拮抗剂、抗惊厥药(如γ-氨基丁酸类似物)、β受体阻滞剂、α-2激动剂、瞬时受体电位香草酸受体激动剂(辣椒素)和糖皮质激素。其他药理学方式包括中枢神经轴技术、手术部位浸润和区域麻醉。有证据支持将这些药理学技术作为多模式镇痛的一部分使用,但每种技术都有其自身的优点和特定的安全性,这凸显了为每位患者选择合适镇痛药物的重要性。辅助性非药理学技术包括针灸、音乐疗法、经皮电刺激神经疗法和催眠。关于这些技术的证据不一,不过使用它们并无危害。
多模式镇痛技术不断进步;然而,总体而言术后疼痛仍未得到充分管理。此外,与ERAS相关的多模式疼痛研究中持续存在的一个挑战是难以开展随机试验来确定任何一个组成部分(包括镇痛)的相对重要性。